United States · FDA National Drug Code directory
Pralatrexate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-550_510bc71b-20e4-428a-8fc2-29c9fc20f2f3
- Product NDC
- 65219-550
- Form
- INJECTION
- Composition / generic term
- Pralatrexate
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20221115
- Source listing expiry
- 20261231
Source-listed ingredients
- PRALATREXATE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (65219-550-01) / 1 mL in 1 VIAL, SINGLE-DOSE · 65219-550-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →